General meeting

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end of the third...

The nominating committee in Stille AB (publ) (“Stille”, or “the Company”) shall consist of three members, who shall represent the three shareholders with the highest number of shares willing to participate in the nominating committee, along with the Chairman of the Board. The nominating committee shall be appointed during the fourth quarter based on the shareholding at the end of the third...

Revenue amounted to 138.8 MSEK (127.9), an increase of 8.5 percent, of which a negative organic growth of 1.9 percent. The quarter was negatively impacted by the phase-out of non-strategic products in surgical instruments that began in early 2025 and a negative currency effect. Adjusted for these two factors, underlying organic growth would have amounted to 7.3 percent.

Stille AB (publ) announces new Executive Management team, with the appointment of Niklas Tyrén as Group CFO and Martin Richardson as Group COO.

Stille AB (publ) informs that Johan Lundholm has decided to leave his position as Business Unit Manager for Surgical Tables of Stille to pursue a new opportunity outside the company.

Stille AB (publ) (“Stille”) today confirms that the previously announced acquisition of Surgical Holdings Ltd (“Surgical Holdings”) has been completed. All closing conditions have been satisfied, and the shares have now been transferred to Stille.

Stille AB (publ) today presents the report for the second quarter 2025.

Stille AB (publ) (“Stille”) has entered into an agreement to acquire all shares outstanding in Surgical Holdings (“Surgical Holdings”) for a consideration of approximately GBP 7.7 million (corresponding to SEK 100 million) on a cash and debt-free basis. Through the acquisition, Stille continues its strategic expansion, further strengthening its geographic reach, product- and service offering...

Torshälla, Sweden – 9 May 2025 – The Board of Directors of Stille AB (“Stille”), a leading provider of premium surgical instruments and advanced surgical tables for high-precision procedures, is pleased to announce the appointment of Ulrik Berthelsen as its new Chief Executive Officer, effective 12 May 2025.

The 2025 annual general meeting in Stille AB was held on Wednesday, May 7, 2025, on Norrlandsgatan 11 in Stockholm. The main resolutions passed at the annual general meeting were as follows. More detailed information about the contents of the resolutions may be obtained from the complete notice of the annual general meeting and the complete proposals, which are available on the company’s website...